NARSAD
Welcome, guest
[login or register]
Donate
HomeAbout UsHow to HelpNews & EventsDisorders & ConditionsResearch Center


» Events
- Galas & Scientific
    Symposia

- Parlor Meetings &
    Seminars

- Community
    Fundraisers


» Publications
- NARSAD Research
    Quarterly

- Free Brochures &
    Fact Sheets on
    Mental Illness

- Annual Report

» Streaming Videos
- Healthy Minds

Stay Informed
Research & Giving News Article

EmailPrint
Deep Brain Stimulation Shows Promise for Treatment-Resistant Depression


(Great Neck, NY - ) — A new treatment approach being studied by NARSAD researcher Dr. Helen Mayberg’s team is known as Deep Brain Stimulation (DBS), a reversible method of selective brain lesioning, as an alternative to standard neurosurgical approaches for treating severe, treatment-resistant major depression. Helen S. Mayberg, MD, a NARSAD Distinguished Investigator, of the Rotman Institute, was recently featured in the March, 2005 issue of Neuron magazine. Mayberg’s team introduces the study saying, “Treatment-resistant depression is a severely disabling disorder with no proven treatment options once multiple medications, psychotherapy, and electroconvulsive therapy have failed.” In some individuals, depression resists all of these known, proven treatments in the medical arsenal. Although deep brain stimulation has been used on other parts of the brain to treat epilepsy, Parkinson’s and other diseases, the technique had not previously been tried for treating major depression.

The team’s preliminary research showed that a certain area of the brain – the subgenual cingulated region – is metabolically overactive in patients with treatment resistant depression. Mayberg and her colleagues considered whether they could reduce this level of activity by selectively stimulating this part of the brain, electrically. The procedure for administering DBS involves drilling two openings into the skull, and implanting electrodes in the brain to administer a measured dose of current. Batteries that last for five years are implanted near the collarbone, and can be programmed through the skin.

The results of the study were striking and encouraging: four of six patients who received the treatment showed marked and sustained improvement six months after the procedure. Mayberg’s team writes, “These results suggest…electrical stimulation of the sugenual cingulated white matter can effectively reverse symptoms in otherwise treatment-resistant depression.”


EmailPrint
Media Contact
Kristen Simone
516-829-0091, ext. 241
Upcoming NARSAD Events
Latest News from NARSAD
Spotlight
View Healthy Minds, award-winning public TV series on mental disorders.

Order these new books on schizophrenia and help NARSAD: My Son's Name Was Fred by Gwill Newman, and I Think I Scared Her by Brooke Katz.
Schizophrenia Research Forum

NARSAD Artworks

Health Central

Anchor Magazine

Schizophrenia Digest

NARSAD 60 Cutter Mill Road, Suite 404, Great Neck, New York 11021 USA     phone (800) 829-8289     fax (516) 487-6930     email info@narsad.org
©NARSAD 2008 | privacy policy | legal notices | disclaimers | sitemap | site help | contact us